癌症进展
癌癥進展
암증진전
ONCOLOGY PROGRESS
2014年
5期
502-504
,共3页
胸腺瘤%常规开胸%胸腔镜下治疗
胸腺瘤%常規開胸%胸腔鏡下治療
흉선류%상규개흉%흉강경하치료
Thymoma%conventional thoracotomy%video-assisted thoracoscopic surgery
目的:比较常规开胸与胸腔镜下治疗早期胸腺瘤的临床效果,探讨胸腔镜下治疗早期胸腺瘤的可行性及优越性。方法回顾分析96例常规开胸(40例)和胸腔镜(56例)治疗的早期胸腺瘤患者,观察两种治疗方式的术后临床情况和并发症情况的差异。结果胸腔镜组与常规开胸组相比,手术时间、术后拔管时间和术后住院时间短,术中出血和术后胸腔积液引流量少,差异有统计学意义(P<0.05);胸腔镜组发生并发症的例数少于常规开胸组,差异有统计学意义(P<0.05);随访期间,胸腔镜组无复发和转移者,常规开胸组出现1例。结论胸腔镜较常规开胸治疗早期胸腺瘤具有明显优势。
目的:比較常規開胸與胸腔鏡下治療早期胸腺瘤的臨床效果,探討胸腔鏡下治療早期胸腺瘤的可行性及優越性。方法迴顧分析96例常規開胸(40例)和胸腔鏡(56例)治療的早期胸腺瘤患者,觀察兩種治療方式的術後臨床情況和併髮癥情況的差異。結果胸腔鏡組與常規開胸組相比,手術時間、術後拔管時間和術後住院時間短,術中齣血和術後胸腔積液引流量少,差異有統計學意義(P<0.05);胸腔鏡組髮生併髮癥的例數少于常規開胸組,差異有統計學意義(P<0.05);隨訪期間,胸腔鏡組無複髮和轉移者,常規開胸組齣現1例。結論胸腔鏡較常規開胸治療早期胸腺瘤具有明顯優勢。
목적:비교상규개흉여흉강경하치료조기흉선류적림상효과,탐토흉강경하치료조기흉선류적가행성급우월성。방법회고분석96례상규개흉(40례)화흉강경(56례)치료적조기흉선류환자,관찰량충치료방식적술후림상정황화병발증정황적차이。결과흉강경조여상규개흉조상비,수술시간、술후발관시간화술후주원시간단,술중출혈화술후흉강적액인류량소,차이유통계학의의(P<0.05);흉강경조발생병발증적례수소우상규개흉조,차이유통계학의의(P<0.05);수방기간,흉강경조무복발화전이자,상규개흉조출현1례。결론흉강경교상규개흉치료조기흉선류구유명현우세。
Objective To compare the clinical effect of conventional thoracotomy and video-assisted thoracoscop-ic surgery (VATS) for early thymoma, and to investigate the feasibility and superiority of video-assisted thoracoscop-ic surgery. Method Retrospectively, 96 cases of early thymoma were treated with conventional thoracotomy (40 cas-es) and (VATS) (56 cases) to observe the clinical outcomes and the differences of postoperative complications. Re-sult Compared with conventional thoracotomy group, the operation time, postoperative extubation time and postop-erative hospital stay in VATS group were shorter; Moreover, the intraoperative hemorrhage and postoperative pleural effusion were less in VATS group, and the differences were of statistical significance (P<0.05). In terms of complica-tions, VATS group had significantly fewer cases than that in conventional thoracotomy group (P<0.05). During fol-low-up, there was no recurrence and metastasis in VATS group, however, there was one case in conventional thora-cotomy group. Conclusion VATS has obvious advantages for early thymoma.